Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 25% ± 5% | |
fibroblast | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 399.44 | 1442 / 1445 | 100% | 6.38 | 183 / 183 |
ovary | 100% | 595.57 | 180 / 180 | 100% | 6.26 | 428 / 430 |
lung | 100% | 417.72 | 577 / 578 | 99% | 7.60 | 1147 / 1155 |
brain | 100% | 310.07 | 2632 / 2642 | 99% | 5.40 | 701 / 705 |
prostate | 100% | 483.90 | 245 / 245 | 99% | 6.23 | 495 / 502 |
breast | 100% | 489.56 | 459 / 459 | 98% | 6.09 | 1100 / 1118 |
thymus | 100% | 505.84 | 653 / 653 | 95% | 3.67 | 574 / 605 |
stomach | 100% | 331.10 | 358 / 359 | 95% | 4.21 | 272 / 286 |
intestine | 100% | 474.75 | 966 / 966 | 94% | 3.38 | 493 / 527 |
uterus | 100% | 640.23 | 170 / 170 | 93% | 3.45 | 429 / 459 |
bladder | 100% | 563.00 | 21 / 21 | 93% | 3.74 | 471 / 504 |
pancreas | 98% | 204.19 | 321 / 328 | 95% | 2.93 | 169 / 178 |
skin | 100% | 340.53 | 1803 / 1809 | 92% | 5.34 | 435 / 472 |
kidney | 100% | 317.42 | 89 / 89 | 91% | 3.48 | 824 / 901 |
adrenal gland | 100% | 401.03 | 258 / 258 | 87% | 2.86 | 201 / 230 |
liver | 95% | 141.81 | 215 / 226 | 69% | 1.69 | 280 / 406 |
adipose | 100% | 457.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 500.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 381.10 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 230.63 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 220.12 | 840 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 3.37 | 39 / 45 |
eye | 0% | 0 | 0 / 0 | 75% | 2.44 | 60 / 80 |
lymph node | 0% | 0 | 0 / 0 | 69% | 1.93 | 20 / 29 |
peripheral blood | 54% | 147.10 | 500 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF322 |
Protein name | Zinc finger protein 322 Zinc finger protein 322 (Zinc finger protein 322A) (Zinc finger protein 388) (Zinc finger protein 489) |
Synonyms | ZNF489 ZNF388 ZNF322A |
Description | FUNCTION: Transcriptional activator . Important for maintenance of pluripotency in embryonic stem cells (By similarity). Binds directly to the POU5F1 distal enhancer and the NANOG proximal promoter, and enhances expression of both genes (By similarity). Can also bind to numerous other gene promoters and regulates expression of many other pluripotency factors, either directly or indirectly (By similarity). Promotes inhibition of MAPK signaling during embryonic stem cell differentiation (By similarity). . |
Accessions | ENST00000471278.5 ENST00000622479.4 ENST00000480036.5 ENST00000415922.7 ENST00000607204.5 C9JP13 ENST00000456172.5 Q6U7Q0 |